Stakeholders’ views on drug development: the congenital disorders of glycosylation community perspective

BACKGROUND: Congenital disorders of glycosylation (CDG) are a large family of rare genetic diseases for which therapies are virtually nonexistent. However, CDG therapeutic research has been expanding, thanks to the continuous efforts of the CDG medical/scientific and patient communities. Hence, CDG...

Descripción completa

Detalles Bibliográficos
Autores principales: Monticelli, Maria, Francisco, Rita, Brasil, Sandra, Marques-da-Silva, Dorinda, Rijoff, Tatiana, Pascoal, Carlota, Jaeken, Jaak, Videira, Paula A., dos Reis Ferreira, Vanessa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338569/
https://www.ncbi.nlm.nih.gov/pubmed/35907899
http://dx.doi.org/10.1186/s13023-022-02460-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338569/
https://www.ncbi.nlm.nih.gov/pubmed/35907899
http://dx.doi.org/10.1186/s13023-022-02460-0

Ejemplares similares